L3VLUP
ProSign in

NUS in the 13F filings

Nu Skin Enterprises Inc · CUSIP 67018T105

Sector · Health care services and research
Quarter
Q1 2026Q3 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Quarter end
31 Dec 2022
the date the book describes
Filed
14 Feb 2023
latest of these filings; the earliest 13 Feb 2023
Managers listing it
5
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2022 and Q4 2022; 4 listed it in both
Shares listed
6,820,782
combined, among listed positions
Reported value
$287m
combined, at the quarter end

Managers listing NUS in Q4 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2022, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

5 of 5 holders

ActionFiling
Wellington Management Group LLP3,535,969$149munder 0.1%Added+46,38713 Feb 2023 (the filing on sec.gov)
Renaissance Technologies LLC2,287,596$96m0.13%Trimmed-255,90013 Feb 2023 (the filing on sec.gov)
AQR Capital Management LLC840,592$35m0.08%Added+84,45514 Feb 2023 (the filing on sec.gov)
Bridgewater Associates LP118,143$5.0munder 0.1%Trimmed-20,48513 Feb 2023 (the filing on sec.gov)
Holocene Advisors LP38,482$1.6munder 0.1%Addedn.a.14 Feb 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2022 to Q4 2022, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2023 to 1 in Q1 2026

Tracked managers listing it, at least.

0510152014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
NUS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20137$171mn.a.n.a.
Q3 20137$311mn.a.n.a.
Q4 20139$705mn.a.n.a.
Q1 20145$487mn.a.n.a.
Q2 20145$239mn.a.n.a.
Q3 20142$176mn.a.n.a.
Q4 20141$213mn.a.n.a.
Q1 20155$819mn.a.n.a.
Q2 20155$680mn.a.n.a.
Q3 20156$492mn.a.n.a.
Q4 20153$181mn.a.n.a.
Q1 20164$172mn.a.n.a.
Q2 20161$50mn.a.n.a.
Q3 20166$99mn.a.n.a.
Q4 20164$86mn.a.n.a.
Q1 20176$228mn.a.n.a.
Q2 20174$250mn.a.n.a.
Q3 20173$236mn.a.n.a.
Q4 20175$257mn.a.n.a.
Q1 20189$351mn.a.n.a.
Q2 20188$288mn.a.n.a.
Q3 201812$423mn.a.n.a.
Q4 201810$304mn.a.n.a.
Q1 201911$187mn.a.n.a.
Q2 201911$262mn.a.n.a.
Q3 201911$382mn.a.n.a.
Q4 201910$326mn.a.n.a.
Q1 20206$61mn.a.n.a.
Q2 202010$327mn.a.n.a.
Q3 202013$460mn.a.n.a.
Q4 202010$508mn.a.n.a.
Q1 20217$497mn.a.n.a.
Q2 20219$541mn.a.n.a.
Q3 20216$233mn.a.n.a.
Q4 202110$476mn.a.n.a.
Q1 20227$409mn.a.n.a.
Q2 20227$366mn.a.n.a.
Q3 20225$268mn.a.n.a.
Q4 20225$287mn.a.n.a.
Q1 20233$238mn.a.n.a.
Q2 20233$98mn.a.n.a.
Q3 20235$77mn.a.n.a.
Q4 20235$49m41
Q1 20241$264k01
Q2 20241$515k10
Q3 20241$580k10
Q4 20241$299k01
Q3 20251$11m01
Q1 20261$13m127

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NUS and UNH →NUS and ELV →NUS and CI →Choose a stock to compare with NUS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NUS, latest filings →Back to the 13F Explorer →